It sounds as if you haven't gone back on HRT--?
ET and EPT increase the risk for venous thromboembolism, although the absolute number of events and the risk are both small.
Though there is a small increase in the number of breast cancers in women who have used menopausal HT for more than 10 years, the biological meaning of this observation (cause versus unmasking versus chance) is unresolved.
Most evidence shows that menopausal HT does not affect breast cancer recurrence and that overall longevity is higher in breast cancer survivors who select menopausal HT. Strong basic science and clinical observational evidence show a benefit of menopausal HT in the cardiovascular and central nervous systems.
Users browsing this forum: No registered users